Introduction to the special issue on antimicrobial stewardship

Pharmacotherapy

Volumn 32, Issue 8, 2012, Pages 663-664

  Goff, Debra A ^a   Rybak, Michael J ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c DETROIT MEDICAL CENTER   (United States)

Author keywords

Antimicrobial stewardship; Critical reviews; Multidrug resistant bacteria; Outcomes

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED PNEUMONIA; DECISION SUPPORT SYSTEM; DIAGNOSTIC TEST; DRUG PROGRAM; DRUG UTILIZATION; EDITORIAL; HEALTH CARE; HUMAN; INTENSIVE CARE; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT SELECTION; PHARMACIST ATTITUDE; PROGRAM DEVELOPMENT;

ANTI-INFECTIVE AGENTS; DRUG DISCOVERY; DRUG RESISTANCE, MICROBIAL; HUMANS;

EID: 84864590676     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01182.x     Document Type: Editorial

References (3)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE Jr, Gilbert D, Rice LB. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48(1):1-12.
2. Bartlett JG. A call to arms: The imperative for antimicrobial stewardship. Clin Infect Dis 2011;54(suppl 1):S4-7.
3. Srinivasan A, Fishman N. Antimicrobial stewardship 2012: Science driving practice. Infect Control Hosp Epidemiol 2012;33(4):319-21.